Molecular genetics of tetrahydrobiopterin deficiency in Chinese patients

Abstract Background The overall incidence of hyperphenylalaninemia (HPA) in China is 1:11,763, with tetrahydrobiopterin (BH4) deficiency accounting for 8.55% of patients with HPA in the mainland. Much progress has been made in the diagnosis and treatment of BH4 deficiency with the introduction of neonatal screening in China. However, the screening rate is still low and screening is not universally available. Methods A total of 44 BH4-deficient patients were enrolled in this study, of which 39 were diagnosed with BH4 deficiency, while the remaining five showed typical characteristics of BH4 deficiency at a later period. The entire coding regions and adjacent intronic regions of GCH1, PTS, PCBD1 and QDPR genes were analyzed using target sequencing. Results Nineteen (n=19) different mutations in the PTS gene including four novel mutations and one mutation in QDPR were identified. p.P87S, p.D96N, IVS1-291A>G, p.N52S, p.K91R, p.V56M, p.T106M and p.F40GfsX53 in PTS were the prevalent mutations with ≥3% relative frequency. The mutation p.R221X in the QDPR gene was found with relatively lower frequencies (2.27%). The remaining 12 mutations in PTS were found at relative frequencies of 1.14%. Conclusions The results could be of value for genetic counseling and prenatal diagnosis in the patients’ families and for the molecular diagnosis of BH4 deficiencies. Furthermore, four novel mutations expand and improve the PTS mutation database.

[1]  J. Liu,et al.  Applying targeted next generation sequencing to dried blood spot specimens from suspicious cases identified by tandem mass spectrometry-based newborn screening , 2017, Journal of pediatric endocrinology & metabolism : JPEM.

[2]  T. Sicheritz-Pontén,et al.  Comparative performance of the BGISEQ-500 vs Illumina HiSeq2500 sequencing platforms for palaeogenomic sequencing , 2017, GigaScience.

[3]  Hui Jiang,et al.  A reference human genome dataset of the BGISEQ-500 sequencer , 2017, GigaScience.

[4]  Yong-hui Jiang,et al.  Genetic Variants Identified from Epilepsy of Unknown Etiology in Chinese Children by Targeted Exome Sequencing , 2017, Scientific Reports.

[5]  M. Alaei,et al.  Four Years of Diagnostic Challenges with Tetrahydrobiopterin Deficiencies in Iranian Patients. , 2016, JIMD reports.

[6]  X. Yi,et al.  A novel missense NMNAT1 mutation identified in a consanguineous family with Leber congenital amaurosis by targeted next generation sequencing. , 2015, Gene.

[7]  T. Sokolsky,et al.  Development of DNA Confirmatory and High-Risk Diagnostic Testing for Newborns Using Targeted Next-Generation DNA Sequencing , 2014, Genetics in Medicine.

[8]  M. Alaei,et al.  Molecular Characterization of QDPR Gene in Iranian Families with BH4 Deficiency: Reporting Novel and Recurrent Mutations. , 2015, JIMD reports.

[9]  Fast clinical molecular diagnosis of hyperphenylalaninemia using next-generation sequencing-based on a custom AmpliSeq™ panel and Ion Torrent PGM sequencing. , 2014, Molecular genetics and metabolism.

[10]  X. Gu,et al.  QDPR gene mutation and clinical follow-up in Chinese patients with dihydropteridine reductase deficiency , 2014, World Journal of Pediatrics.

[11]  Shujian Cui,et al.  Mutation Spectrum of Six Genes in Chinese Phenylketonuria Patients Obtained through Next-Generation Sequencing , 2014, PloS one.

[12]  L. Armengol,et al.  Accurate molecular diagnosis of phenylketonuria and tetrahydrobiopterin-deficient hyperphenylalaninemias using high-throughput targeted sequencing , 2013, European Journal of Human Genetics.

[13]  D. Hougaard,et al.  Archived neonatal dried blood spot samples can be used for accurate whole genome and exome-targeted next-generation sequencing. , 2013, Molecular genetics and metabolism.

[14]  S. Zeinali,et al.  A novel PCBD gene mutation in an Iranian patient with hyperphenylalaninemia. , 2013, Clinical laboratory.

[15]  Xuefan Gu,et al.  Demographics, diagnosis and treatment of 256 patients with tetrahydrobiopterin deficiency in mainland China: results of a retrospective, multicentre study , 2013, Journal of Inherited Metabolic Disease.

[16]  Dong Hwan Lee,et al.  Mutation spectrum of and founder effects affecting the PTS gene in East Asian populations , 2012, Journal of Human Genetics.

[17]  J. Marin,et al.  A homozygous nonsense mutation (c.214C→A) in the biliverdin reductase alpha gene (BLVRA) results in accumulation of biliverdin during episodes of cholestasis , 2011, Journal of Medical Genetics.

[18]  Yin-Hsiu Chien,et al.  Nationwide survey of extended newborn screening by tandem mass spectrometry in Taiwan , 2010, Journal of Inherited Metabolic Disease.

[19]  Mohsin Shahzad,et al.  Targeted capture and next-generation sequencing identifies C9orf75, encoding taperin, as the mutated gene in nonsyndromic deafness DFNB79. , 2010, American journal of human genetics.

[20]  N. Blau,et al.  Phenotypic variability, neurological outcome and genetics background of 6‐pyruvoyl‐tetrahydropterin synthase deficiency , 2010, Clinical genetics.

[21]  Ying Hui Cao,et al.  The profile of newborn screening coverage in China , 2009, Journal of medical screening.

[22]  W. Wang,et al.  China: Public Health Genomics , 2009, Public Health Genomics.

[23]  N. Longo.  Disorders of biopterin metabolism , 2009, Journal of Inherited Metabolic Disease.

[24]  X. Gu,et al.  [The investigation of differential diagnostic development and incidence of tetrahydrobiopterin deficiency]. , 2009, Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine].

[25]  P. Guldberg,et al.  Molecular analysis of 16 Turkish families with DHPR deficiency using denaturing gradient gel electrophoresis (DGGE) , 2000, Human Genetics.

[26]  S. Henikoff,et al.  Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm , 2009, Nature Protocols.

[27]  Xuefan Gu,et al.  Newborn screening in China: phenylketonuria, congenital hypothyroidism and expanded screening. , 2008, Annals of the Academy of Medicine, Singapore.

[28]  A. Felice,et al.  Molecular genetics of tetrahydrobiopterin (BH4) deficiency in the Maltese population. , 2007, Molecular genetics and metabolism.

[29]  Nenad Blau,et al.  Mutations in the BH4‐metabolizing genes GTP cyclohydrolase I, 6‐pyruvoyl‐tetrahydropterin synthase, sepiapterin reductase, carbinolamine‐4a‐dehydratase, and dihydropteridine reductase , 2006, Human mutation.

[30]  I. Barnes,et al.  International database of tetrahydrobiopterin deficiencies , 1996, Journal of Inherited Metabolic Disease.

[31]  S. Chiang,et al.  Tetrahydrobiopterin-deficient hyperphenylalaninemia in the Chinese. , 2001, Clinica chimica acta; international journal of clinical chemistry.

[32]  N. Blau,et al.  Tetrahydrobiopterin deficiencies without hyperphenylalaninemia: diagnosis and genetics of dopa-responsive dystonia and sepiapterin reductase deficiency. , 2001, Molecular genetics and metabolism.

[33]  N. Blau,et al.  Tetrahydrobiopterin biosynthesis, regeneration and functions. , 2000, The Biochemical journal.

[34]  N. Blau,et al.  Mutations in the GTP cyclohydrolase I and 6‐pyruvoyl‐tetrahydropterin synthase genes , 1997, Human mutation.

[35]  D. Howells,et al.  Identification and in vitro expression of mutations causing dihydropteridine reductase deficiency. , 1993, Biochemistry.